Therapy for beta-thalassemia--a paradigm for the treatment of genetic disorders

Editorial

G J Dover et al. N Engl J Med. 1994.

. 1994 Sep 1;331(9):609-10.

doi: 10.1056/NEJM199409013310911.

No abstract available

Comment on

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW. Brittenham GM, et al. N Engl J Med. 1994 Sep 1;331(9):567-73. doi: 10.1056/NEJM199409013310902. N Engl J Med. 1994. PMID: 8047080
Survival in medically treated patients with homozygous beta-thalassemia.
Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Olivieri NF, et al. N Engl J Med. 1994 Sep 1;331(9):574-8. doi: 10.1056/NEJM199409013310903. N Engl J Med. 1994. PMID: 8047081